Sitapride-M 50/1000 Tablet SR is a combination medication containing Sitagliptin and Metformin, designed to help manage high blood sugar levels in individuals with type 2 diabetes mellitus. By controlling blood sugar levels, this medication can assist in preventing serious complications associated with diabetes such as kidney damage, blindness, heart attacks, and strokes.

This medication can be prescribed either as a standalone treatment or in conjunction with other diabetes medications. To achieve the best results, it is recommended to incorporate a healthy diet and regular exercise routine alongside the medication. The dosage prescribed will be tailored to your specific condition, blood sugar levels, and concurrent medications. Taking Sitapride-M 50/1000 Tablet SR with meals can help reduce the likelihood of experiencing stomach upset.

Consistency is key when taking this medication – it is important to adhere to a regular schedule, taking it at the same time each day, as advised by your healthcare provider. You should not discontinue the medication unless instructed by your doctor. Following the diet and exercise regimen outlined by your healthcare provider is crucial in managing diabetes, as lifestyle factors significantly impact the condition.

Common side effects of Sitapride-M 50/1000 Tablet SR include diarrhea, nausea, vomiting, upset stomach, headache, and sore throat. Additionally, hypoglycemia (low blood sugar levels) may occur, especially when using other diabetes medications concurrently. Recognizing and managing hypoglycemia is important to avoid complications.

Certain individuals may not be suitable candidates for this medication. Before starting treatment, inform your doctor of any history of kidney, liver, or heart disease, pancreatic issues, or alcohol consumption habits. Pregnant or breastfeeding individuals should also consult their healthcare provider before taking Sitapride-M 50/1000 Tablet SR. It is essential to disclose all medications you are currently taking to ensure safety and effectiveness. Monitoring of kidney function and blood sugar levels will be conducted throughout the treatment period.